Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency
Julia R. Hirsiger, Sebastian Weigang, Antje‐Christine Walz, Jonas Fuchs, Mary-Louise Daly, Stefan Eggimann, Oliver Hausmann, Martin Schwemmle, Georg Kochs, Marcus Panning, Klaus Warnatz, Mike Recher, Christoph T. Berger
Topics & Concepts
MedicineAntibodyVaccinationImmunologyCommon variable immunodeficiencyPopulationImmunizationImmunoglobulin GVirologyImmunodeficiencyImmune systemEnvironmental healthImmunodeficiency and Autoimmune DisordersPlatelet Disorders and TreatmentsSARS-CoV-2 and COVID-19 Research